Prillaman H M, Cox S B, Freedlender A E, Cornett G E, Jones H A, Flanagan T L, Chance R E, Hoffmann J A, Andersen D K, Elahi D
Department of Medicine, University of Virginia, Charlottesville.
Ann Surg. 1992 Nov;216(5):574-82. doi: 10.1097/00000658-199211000-00009.
Surgical alterations of the pancreas result in anatomic changes that can affect postoperative glucose metabolism. Pancreas transplantation results in reduction of beta-cell mass, systemic release of insulin, and denervation. The authors hypothesized that such alterations affect peripheral glucose disposal to induce an "insensitivity" to endogenously (systemically) released insulin. Additionally, they hypothesized that surgically induced deficiency of the postprandial hormone, pancreatic polypeptide, might contribute to altered glucose disposal. The authors studied two surgical models in dogs known to be devoid of pancreatic polypeptide--70% proximal pancreatectomy (PPx) and PPx plus distal pancreas autotransplantation (PAT/B). Oral glucose challenge and euglycemic hyperinsulinemic clamp studies were performed before and after a 16-day "pulsed" infusion of pancreatic polypeptide. Both surgical procedures resulted in elevations in the integrated glucose response after oral glucose, which was not affected by pancreatic polypeptide infusion. Euglycemic clamp studies showed decreased hepatic glucose output (Ra) and overall glucose disposal (Rd) in the fasted state for both surgical groups. The transplant animals demonstrated significant decreases in Rd during the hyperinsulinemic challenge (3.2 +/- 0.01 versus 5.7 +/- 0.01 mg/kg/minute at 60 to 120 minutes for PAT/B versus control). After 16 days of pancreatic polypeptide infusion, however, basal Ra, as well as basal and 60- to 120-minute Rd values, were returned to control values in the transplant group. The authors conclude that pancreas transplantation results in altered glucose disposal, possibly due to an altered effectiveness of systemically released insulin. They conclude that pancreatic polypeptide is an important modulator of peripheral insulin action. Therefore, the role of pancreatic polypeptide must be taken into account when evaluating postoperative glucose metabolism in canine models of pancreas transplantation.
胰腺手术改变会导致解剖结构变化,进而可能影响术后糖代谢。胰腺移植会导致β细胞量减少、胰岛素的全身释放以及去神经支配。作者推测,这些改变会影响外周葡萄糖处置,从而导致对内源性(全身性)释放胰岛素产生“不敏感”。此外,他们还推测,手术引起的餐后激素——胰多肽缺乏,可能会导致葡萄糖处置改变。作者研究了两种已知缺乏胰多肽的犬类手术模型——70%近端胰腺切除术(PPx)和PPx加远端胰腺自体移植(PAT/B)。在进行16天的胰多肽“脉冲式”输注前后,分别进行了口服葡萄糖耐量试验和正常血糖高胰岛素钳夹试验。两种手术操作均导致口服葡萄糖后葡萄糖综合反应升高,且不受胰多肽输注的影响。正常血糖钳夹研究表明,两个手术组在禁食状态下肝葡萄糖输出量(Ra)和总体葡萄糖处置量(Rd)均降低。移植动物在高胰岛素刺激期间的Rd显著降低(PAT/B组在60至120分钟时为3.2±0.01,对照组为5.7±0.01mg/kg/分钟)。然而,在输注胰多肽16天后,移植组的基础Ra以及基础和60至120分钟的Rd值恢复到了对照值。作者得出结论,胰腺移植导致葡萄糖处置改变,可能是由于全身释放胰岛素的有效性改变所致。他们得出结论,胰多肽是外周胰岛素作用的重要调节因子。因此,在评估胰腺移植犬模型的术后糖代谢时,必须考虑胰多肽的作用。